放射腫瘤學市場報告：趨勢、預測和競爭分析（至 2031 年）

由於攝護腺癌、乳癌、肺癌、大腸直腸癌和子宮頸癌市場存在機會，全球放射治療市場的未來前景光明。預計到 2031 年全球放射治療市場規模將達到 113 億美元，2025 年至 2031 年的複合年成長率為 5.9%。該市場的主要促進因素是癌症發生率的增加、放射治療技術的進步以及老年人口的增加。

• 根據 Lucintel 的預測，基於類型，外部放射線治療預計將成為預測期內最大的細分市場。這是因為，將輻射精確地引導至癌細胞，使得腫瘤學家能夠使用更高劑量的放射線治療進行治療，同時對正常組織造成更少的損害。
• 根據應用，前列腺癌預計將繼續成為最大的細分市場，因為前列腺癌的發生率不斷增加，且與其他類型的癌症相比成功率更高。
• 根據地區分類，預計亞太地區將在預測期內實現最高成長，這得益於該地區人們對放射治療認知的不斷提高、醫療保健支出的不斷增加以及老年人口的不斷成長。

放射腫瘤學市場的策略性成長機會

隨著新應用和新技術的出現，治療的廣度和深度不斷增加，放射治療市場在未來幾年具有巨大的成長潛力。癌症發生率不斷上升，需要先進的治療以及更有針對性的治療方法，這為各種應用創造了策略性成長機會。

• 質子治療中心擴建：質子治療中心擴建是放射治療產業一個有吸引力的成長機會。隨著質子治療的副作用更少、標靶性更高等優點得到越來越廣泛的認可，對質子治療的需求也日益增加。世界各地正在建立新的質子治療中心，特別是在美國等無法獲得晚期癌症治療的國家。因此，放射治療市場的成長預計將受到質子治療日益普及的推動，這將使更多人能夠負擔得起質子治療的成本並提高其接受度。
• 個人化治療中人工智慧的應用成長：市場對利用人工智慧進行臨床放射治療規劃的興趣日益濃厚。人工智慧可以評估許多變量，從而可以創建個人化的治療方法，最大限度地提高療效並最大限度地減少副作用。隨著人工智慧的發展，放射治療的應用範圍將不斷擴大，預計治療效果和患者照護將進一步改善。這一趨勢正在刺激基於人工智慧的新產品和軟體的成長，它們很可能在未來的放射腫瘤學市場中發揮核心作用。
• 擴大低分次放射治療：隨著臨床醫師和患者尋求更好、更快的治療方法，低分次放射治療的應用不斷擴大。低分次放射治療可在較短時間內完成治療，從而減輕醫療系統的負擔並改善患者體驗。這對於癌症治療尤其有利，因為癌症治療需要在短時間內釋放高劑量的輻射。

隨著低分次放射治療越來越被採用，預計市場將會擴大，因為它是一種低成本、低侵入性的治療方法，特別是對於患有多種健康問題的人。

• 新興市場的放射腫瘤學擴張：新興市場為放射腫瘤學服務的成長提供了巨大的機會。這些地區擁有發達的醫療保健基礎設施，對包括放射治療在內的先進癌症治療的需求日益成長。新興市場政府和私人醫療部門正在大力投資建造放射治療中心和實施最新技術。此次擴張預計將為全球更多的患者提供先進的癌症治療，從而支持放射治療市場。隨著這些新興市場不斷發展，它們很可能在整個放射腫瘤學市場的成長和發展中發揮關鍵作用。

放射治療市場的策略成長機會包括新質子治療中心的開設、人工智慧在個人化治療中的整合、低分次放射治療的擴展、新興經濟體的成長以及與免疫療法的合作以顯著改善癌症治療。針對這些機會的策略不僅擴大了放射治療的範圍，而且還提高了其療效並改善了患者的治療效果。預計此類變化將在不久的將來發生，並將影響放射治療市場的成長，旨在更有效地為更多患者提供個人化的癌症管理治療。

放射腫瘤學市場促進因素與挑戰

放射治療市場受到技術發展、經濟因素和法規交互作用的影響。雖然這些方面刺激了創新和市場擴張，但也帶來了重大挑戰，必須解決才能避免停滯。主要促進因素包括癌症患者數量的增加、放射治療技術的改進、對醫療費用的支持、對放射治療認知的不斷提高以及政府加強癌症治療的計劃。

推動放射治療市場成長的因素有：

• 癌症發生率上升：癌症發生率上升：全球癌症患者數量的增加是放射治療市場發展的主要驅動力。由於人口老化和生活方式因素導致癌症風險增加，對有效治療方案的需求日益增加。隨著生活方式改變、人口老化和環境影響等各種因素導致癌症患者數量增加，放射治療的需求變得更加突出。
• 技術進步：放射技術的快速進步，例如質子治療、MR-linac 系統和 AI 整合的發展，正在提高放射治療的有效性和效率。這些技術使治療更安全、更精確，更多患者也更容易接受。
• 政府承諾和資金：政府正在增加對醫療保健舉措的投資，旨在改善癌症護理基礎設施並擴大放射治療的機會。這些舉措提高了人們對治療中心的認知和可用性，為市場成長做出了巨大貢獻。
• 患者的認知和接受度：隨著對癌症治療和放射治療益處的認知不斷提高，越來越多的患者接受治療。這種觀念的轉變對市場需求產生了正面影響。

阻礙放射腫瘤學市場成長的挑戰是：

• 設備和治療成本不斷上漲：先進放射治療設備的初始安裝成本高昂，這可能會使一些醫療機構（尤其是新興市場的醫療機構）難以採用新技術。高昂的費用可能會限制人們獲得現代放射治療的選擇。
• 訓練有素的專業人員短缺：合格的放射腫瘤學家、醫學物理學家和其他訓練有素的人員的短缺會阻礙先進放射治療技術的有效實施。這種差距可能會延遲患者獲得護理的機會並影響治療結果。
• 監管挑戰：放射治療產業必須適應各國不同的複雜監管環境。遵守嚴格的法規可能會導致產品上市延遲，並增加引入新技術的成本。
• 病患特定因素：個別病患的健康狀況和遺傳傾向可能會影響治療結果。了解這些因素對於個人化放射治療至關重要，但在治療通訊協定中充分解決這些因素仍有挑戰。

總之，放射腫瘤學市場雖然受到多種成長要素的推動，但也面臨重大挑戰。平衡這些因素是推動該領域發展和確保患者接受最有效和最容易獲得的治療的關鍵。

目錄

第1章執行摘要

第 2 章全球放射腫瘤學市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業促進因素與挑戰

第 3 章 市場趨勢與預測分析（2019-2031）

• 宏觀經濟趨勢（2019-2024）與預測（2025-2031）
• 全球放射腫瘤學市場趨勢（2019-2024 年）與預測（2025-2031 年）
• 全球放射治療市場按類型
  • 外部放射治療
  • 體內放射療法
  • 全身放射線治療
• 全球放射腫瘤學市場（按應用）
  • 攝護腺癌
  • 乳癌
  • 肺癌
  • 大腸直腸癌
  • 子宮頸癌
  • 其他
• 全球放射腫瘤學市場（按最終用途分類）
  • 醫院
  • 獨立放射治療中心
  • 其他

第 4 章。

• 全球放射腫瘤學市場（按地區）
• 北美放射腫瘤學市場
• 歐洲放射治療市場
• 亞太地區放射腫瘤學市場
• 世界其他地區的放射治療市場

第5章 競爭分析

• 產品系列分析
• 業務整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球放射腫瘤學市場成長機會（按類型）
  • 全球放射腫瘤學市場的成長機會（按應用）
  • 全球放射腫瘤學市場成長機會（依最終用途分類）
  • 全球放射腫瘤學市場各區域成長機會
• 全球放射治療市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球放射治療市場容量不斷擴大
  • 全球放射腫瘤學市場的合併、收購和合資企業
  • 認證和許可

第7章主要企業公司簡介

• Ion Beam Applications
• Elekta
• Accuray Incorporated
• Isoray
• Becton
• Dickinson and Company
• Siemens Healthineers
• ICAD
• Nordion
• MEVION MEDICAL SYSTEMS

The future of the global radiotherapy market looks promising with opportunities in the prostate cancer, breast cancer, lung cancer, colorectal cancer, and cervical cancer markets. The global radiotherapy market is expected to reach an estimated $11.3 billion by 2031 with a CAGR of 5.9% from 2025 to 2031. The major drivers for this market are the increasing cancer incidence, advancements in radiotherapy technology, and the growing geriatric population.

• Lucintel forecasts that, within the type category, external beam radiation therapy will remain the largest segment over the forecast period due to the accuracy of the direct beams at the cancerous cells, which results in less damage to normal tissues, while allowing oncologists to use higher doses of radiotherapy for treatment.
• Within the application category, prostate cancer will remain the largest segment due to the growing incidence of prostate cancer and higher success rate as compared to other cancer types.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the growing awareness about radiotherapy, rising healthcare expenditure, and increasing geriatric population in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Radiotherapy Market

The phenomenon and trends prevailing in the radiotherapy market are changing for the better due to technological advancements, changing healthcare needs, and the search for more efficient ways to treat cancer. New developments in this area, expanding beyond the limited view of seeking only cancer cures, are improving not only the effectiveness of radiotherapy but also reinforcing its use in a greater variety of cancers and for more patients. As healthcare institutions and practitioners remain innovative, it is safe to say that these trends will transform the cancer care sector for the better by providing more treatment options and offering greater hope to patients.

• Proton Therapy Expansion: Proton therapy is emerging as one of the leading approaches in the treatment of specific tumor types, especially those located close to critical organs such as the brain and spinal cord. This trend stems from the fact that high doses of radiation can be delivered within a shorter distance from the tumor while inflicting less or no damage to normal tissue. Several proton therapy facilities are being established globally, thereby increasing the accessibility of advanced treatment to a growing pool of patients. More facilities and manpower are expected to be developed for the administration of proton therapy, further diversifying the radiotherapy industry and improving outcomes.
• Integration of Artificial Intelligence (AI): Artificial intelligence is changing the landscape of the radiotherapy market by increasing the precision and speed of treatment planning and delivery. Complex images are analyzed, the optimal radiation dose is determined, and the outcomes for each patient are predicted as accurately as possible, thanks to specially developed AI algorithms. This approach is also helping to shorten the treatment planning phase, reducing the waiting period for patients before treatment commences. Improvements in AI will enhance integration in radiotherapy, with expectations for greater precision in treatments, fewer adverse effects, and better results for patients.
• Increasing Use of Image-Guided Radiotherapy (IGRT): Recently, there has been a significant advent of new technology in Image-Guided Radiotherapy (IGRT). IGRT includes the availability of live images, such as Computed Tomography (CT) or MRI-guided tumor volume imaging, during radiotherapy delivery. This allows for adjustments during treatment to accommodate tumor movements or patient repositioning. The increasing use of IGRT is enhancing treatment accuracy, lowering unintended radiation doses to patients, and improving the prospects of radiation therapy for more types of cancer.
• Combination of Radiotherapy with Immunotherapy: Integrating radiotherapy with immunotherapy is a new trend that has high potential and will improve outcomes in cancer treatment. Immunotherapy enhances the body's immune response to detect and address cancerous tissues, complementing radiotherapy that involves radiation exposure. This combination treatment strategy is effective for cancers that do not respond to conventional treatment approaches. Research is ongoing, and clinical trials are underway to establish the best combinations and sequences of such treatments to ensure their maximal effect and broaden their clinical applications.

Newly developed concepts within the radiotherapy market, such as management of proton therapy by centers, incorporation of AI, the rise in application of IGRT, combination with immunotherapy, and individualization of treatment, stand to change the narrative around cancer treatment. These improvements are not just augmenting the accuracy and efficacy of radiotherapy techniques; they are also expanding the scope of radiotherapy usage for more patients with various oncological diseases. As these trends advance, they are poised to propel the growth of the radiotherapy market and improve the prognosis for patients diagnosed with cancer worldwide.

Recent Developments in the Radiotherapy Market

The radiotherapy market is inundated with new technologies, approved regulations, and increasing investment interest due to cancer treatments. All these developments aim to enhance the quality of radiotherapy treatments and improve patient outcomes. As the demand for advanced cancer therapies increases, the thermotherapy market is expanding, showcasing advanced techniques and equipment to develop individualized therapies targeting specific ailments.

• Advancement in Proton Therapy: Proton therapy has developed significantly and has emerged as a breakthrough in the radiotherapy market, as it offers better chances of targeting tumor regions without harming healthy tissues. Recently, efforts have focused on making proton therapy more viable and addressing existing limitations in the number of centers offering this therapy due to high costs. These trends encourage the use of proton therapy for many more malignancies, even those currently treated solely with surgical methods or those resistant to conventional radiotherapy. The rise in the availability of proton therapy services is anticipated to have substantial potential in the radiotherapy market by reaching more patients.
• Integration of Artificial Intelligence in Treatment Planning: The use of artificial intelligence (AI) in the planning of radiotherapy treatments is changing the market for the better by increasing the efficiency and accuracy of treatment protocols. Recently, AI is being applied to manage patient information, optimize radiation doses, and predict outcomes. This evolution not only shortens the duration of treatment planning but also facilitates greater individualization in treatment approaches. Continued advancements in AI will further enhance its effectiveness in radiotherapy, contributing to market growth.
• Expansion of Stereotactic Body Radiotherapy (SBRT): Stereotactic Body Radiotherapy (SBRT) is quickly becoming the conventional option for managing specific types of cancer, particularly carcinomas of the lung, liver, and spine. Delivery of SBRT typically occurs in three to five treatment sessions rather than the numerous fractions traditionally offered, resulting in fewer complications compared to surgical approaches. The last decade has focused on improving SBRT modalities, refining patient selection, and broadening its application for additional oncological indications. Given the clinically satisfactory results achieved, the market for these systems is expected to grow as more patients seek effective yet less harmful treatment through SBRT.
• Development of MR-Linac Technology: The advancement of Magnetic Resonance Linear Accelerator (MR-Linac) technology represents a revolutionary advance in radiation oncology. MR-Linac allows for tumor visualization while directing radiation, leveraging the benefits of MRI and the linear accelerator. This technology enhances radiation delivery to the tumor and allows for adjustments based on tumor movement, making treatment more effective and minimizing side effects. The emergence of MR-Linac technology improves the effectiveness of radiotherapy for complex and mobile tumors, thus positively contributing to the growth of the radiotherapy market.

Recent trends in the radiotherapy market, such as the advent of proton therapy, incorporation of artificial intelligence, expansion of SBRT, MR-Linac technology, and hypofractionated radiotherapy, are transforming cancer treatment. These developments are not only increasing the accuracy and efficacy of radiotherapy but also enhancing the affordability and convenience of this treatment.

Strategic Growth Opportunities for Radiotherapy Market

There is substantial growth potential in the radiotherapy market in the coming years as new applications and technologies emerge, enhancing the breadth and depth of therapies. Strategic growth opportunities are arising in different applications due to the rising incidence of cancer requiring advanced treatment alongside more targeted approaches.

• Expansion of Proton Therapy Centers: The expansion of proton therapy centers presents an attractive growth opportunity in the radiotherapy industry. Demand for such therapy is increasing as the advantages of proton therapy, such as lower side effects and higher targeting precision, become more recognized. New proton therapy centers are being established worldwide, especially in countries where advanced cancer treatments are limited, such as in the US. Therefore, it is predicted that the growth of the radiotherapy market will be driven by increased proton therapy usage, making it affordable to a larger population and encouraging its acceptance.
• Growth in the Use of AI for Personalized Treatment: There is growing market interest in utilizing AI for clinical radiation therapy planning. AI can evaluate many variables, allowing for the creation of individualized therapies that maximize efficacy and minimize adverse effects. Continued developments in AI will lead to broader applications in radiotherapy, further improving the effectiveness of procedures and patient care. This trend is fueling the growth of new AI-based products and software that are likely to play a central role in the future of the radiotherapy market.
• Expansion of Hypofractionated Radiotherapy: The use of hypofractionated radiotherapy continues to grow as clinicians and patients seek better and faster treatment methods. Hypofractionation involves delivering treatment over a shorter period, easing the burden on the healthcare system and improving patient experience. This is particularly favorable for treating cancers with shorter, higher radiation doses.

With the increasing adoption of hypofractionated radiotherapy, market expansion is anticipated, as this is a low-cost and less cumbersome treatment option, especially for populations with diverse health concerns.

• Radiotherapy Expansion in Emerging Markets: Emerging markets offer significant opportunities for the growth of radiotherapy services. With improvements in healthcare infrastructure in these regions, the demand for advanced cancer therapies, including radiotherapy, is rising. Governments and private health sectors in emerging markets are investing heavily in building radiotherapy centers and deploying modern technology. This escalation is expected to support the radiotherapy market by providing advanced cancer treatment to more patients than ever before on a global scale. As these markets continue to develop, they are likely to play a vital role in the overall growth and development of the radiotherapy market.

Strategic growth opportunities in the radiotherapy market are being driven by the establishment of new proton therapy centers, the integration of artificial intelligence in personalized treatment, the expansion of hypofractionated radiotherapy, growth in developing economies, and collaboration with immunotherapy to significantly improve cancer treatment. Strategies targeting these opportunities are not just widening the scope of radiotherapy; they are also enhancing its efficacy and improving patient outcomes. These changes are anticipated to develop in the near future and will influence the growth of the radiotherapy market toward delivering personalized cancer management therapies efficiently to more patients.

Radiotherapy Market Driver and Challenges

The radiotherapy market is shaped by the interplay between technological development, economic factors, and regulations. These aspects spur innovation and market expansion while also presenting significant challenges that need to be addressed to avoid stagnation. Key drivers include the rise in cancer cases, technological improvements in radiation therapy, support for healthcare costs, increased awareness of radiotherapy treatments, and government cancer treatment enhancement programs.

The factors responsible for driving the growth of the radiotherapy market are:

• Rising Cancer Incidence: The global increase in cancer cases is a significant driver of the radiotherapy market. With an aging population and lifestyle factors contributing to cancer risk, the demand for effective treatment options is escalating. As cancer cases rise due to various factors like lifestyle changes, population aging, and environmental influences, the need for radiotherapy becomes more pronounced.
• Technological Advancements: Rapid advancements in radiation technology, such as the development of proton therapy, MR-Linac systems, and AI integration, are enhancing the effectiveness and efficiency of radiotherapy. These technologies are making treatments safer, more accurate, and accessible to a broader patient population.
• Government Initiatives and Funding: Governments are increasingly investing in healthcare initiatives aimed at improving cancer treatment infrastructure and expanding access to radiotherapy. These initiatives contribute significantly to market growth by enhancing awareness and increasing the number of available treatment centers.
• Patient Awareness and Acceptance: The growing awareness of cancer treatments and the benefits of radiotherapy is encouraging more patients to seek treatment. This shift in perception is positively influencing market demand.

However, the radiotherapy market faces challenges that may impede growth, including:

• High Costs of Equipment and Treatment: The initial setup costs for advanced radiotherapy equipment are substantial, making it difficult for some healthcare facilities, especially in emerging markets, to adopt new technologies. This high expense can limit access to modern radiotherapy options.
• Shortage of Trained Professionals: A shortage of qualified radiation oncologists, medical physicists, and other trained personnel may hinder the effective implementation of advanced radiotherapy techniques. This gap can delay patient access to treatment and affect outcomes.
• Regulatory Challenges: The radiotherapy industry must navigate complex regulatory landscapes, which can vary by country. Compliance with stringent regulations may lead to delays in product launches and increase the costs associated with new technology adoption.
• Patient-Specific Factors: Individual patient health conditions and genetic predispositions can influence treatment outcomes. Understanding these factors is essential for personalizing radiotherapy, yet challenges remain in adequately addressing them within treatment protocols.

In conclusion, while the radiotherapy market is driven by several growth factors, it also faces significant challenges. Balancing these elements is critical for advancing the field and ensuring patients receive the most effective and accessible treatments possible.

List of Radiotherapy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies radiotherapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the radiotherapy companies profiled in this report include-

• Ion Beam Applications
• Elekta
• Accuray Incorporated
• Isoray
• Becton
• Dickinson and Company
• Siemens Healthineers
• ICAD
• Nordion
• MEVION MEDICAL SYSTEMS

Radiotherapy by Segment

The study includes a forecast for the global radiotherapy market by type, application, end use, and region

Radiotherapy Market by Type [Analysis by Value from 2019 to 2031]:

• External Beam Radiation Therapy
• Internal Radiation Therapy
• Systemic Radiation Therapy

Radiotherapy Market by Application [Analysis by Value from 2019 to 2031]:

• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Cervical Cancer
• Others

Radiotherapy Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Independent Radiotherapy Centers
• Others

Radiotherapy Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Radiotherapy Market

Here's the revised content without single line spaces between sentences, except for headings:

The radiotherapy market is growing at a rapid pace in all parts of the world owing to technological developments, the surge in the number of cancer patients, and the improvement in the status of healthcare services. With the growing recognition of the need for better healthcare, nations are now embracing new methods of radiotherapy and increasing the reach of these services. This growth in demand is additionally attributed to the incorporation of artificial intelligence and precision medicine into the practice of radiotherapy, which increases its effectiveness and safety.

• United States: Among some of the more recent changes in the radiotherapy industry in the United States is the quick adoption of advanced technologies, including proton therapy and SBRT. These modes allow for very precise delivery of radiation to the tumor with minimal damage to the surrounding healthy tissues. Further, the use of artificial intelligence in the treatment planning and delivery mechanisms has boosted the efficiency of radiotherapy, generating commendable results in patients. Finally, the US market is also committing itself to further investments that widen the scope of provision of radiotherapy services, for example, in terms of geography to include rural and clinically underserved regions, in both government and private initiatives.
• China: The radiotherapy market in China is also growing rapidly due to increasing cases of cancer, as well as considerable governmental investments in the healthcare system. Recent developments include improved control of x-ray treatment, where IMRT and IGRT techniques are extensively utilized. Besides, there is considerable activity in the form of building more cancer treatment centers with the best available radiotherapy equipment in China. Collaborations between Chinese institutes and foreign healthcare corporations will also help in the transfer of newer radiotherapy methods and technologies back to China so that it can provide more advanced cancer therapy.
• Germany: * Within the German market of radiotherapy, one has to admit that the country's healthcare is gradually leaning towards models of precision medicine, as well as models that advocate for personalized treatment in generic radiotherapy. Trends such as the growing popularity of using molecular imaging techniques together with radiotherapy to target tumor cells while sparing normal tissues are also underway. Germany is involved in examining strategies that combine radiotherapy with immunotherapy, thereby widening the possibilities for the immune response to tumors. Additionally, the country is working on eliminating geographic barriers for radiotherapy services by increasing the number of specialized centers and adopting state-of-the-art radiotherapy equipment.
• India: There has been significant development in the radiotherapy market in India due to increased awareness, government participation, and public-private partnerships in the cancer treatment sector. This development has led to more complex models evolving in payment structures, which intensify the introduction of advanced radiotherapy methods in cancer hospitals, such as stereotactic radiosurgery (SRS) or brachytherapy. There is also an increased focus on training, education, and orientation of personnel so that professionals can utilize modern radiotherapy technologies. Additionally, there is geographical imbalance in radiotherapy availability. New centers are being created in underserved areas to reduce disparities in cancer treatment across the country.
• Japan: The Japanese radiotherapy market is on an upward trajectory due to the incorporation of newer treatment techniques, including drug delivery using protons and heavy ions for distant and difficult-to-operate tumors. Recent developments also include the use of AI and machine learning in treatment planning, wherein the targeting dose is further improved. Efforts are being made to develop the radiotherapy infrastructure in Japan, with new cancer treatment facilities being built in response to the rising demand for modern cancer treatment services. In addition, there is a greater focus on research and development in the area of radiotherapy, with studies currently being undertaken to combine conventional forms of treatment with others, such as immunotherapy.

Features of the Global Radiotherapy Market

Market Size Estimates: Radiotherapy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Radiotherapy market size by type, application, and region in terms of value ($B).

Regional Analysis: Radiotherapy Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the radiotherapy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the radiotherapy market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the radiotherapy market by type (external beam radiation therapy, internal radiation therapy, and systemic radiation therapy), application (prostate cancer, breast cancer, lung cancer, colorectal cancer, cervical cancer, and others), end use (hospitals, independent radiotherapy centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Radiotherapy Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Radiotherapy Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Radiotherapy Market by Type
  • 3.3.1: External Beam Radiation Therapy
  • 3.3.2: Internal Radiation Therapy
  • 3.3.3: Systemic Radiation Therapy
• 3.4: Global Radiotherapy Market by Application
  • 3.4.1: Prostate Cancer
  • 3.4.2: Breast Cancer
  • 3.4.3: Lung Cancer
  • 3.4.4: Colorectal Cancer
  • 3.4.5: Cervical Cancer
  • 3.4.6: Others
• 3.5: Global Radiotherapy Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Independent Radiotherapy Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Radiotherapy Market by Region
• 4.2: North American Radiotherapy Market
  • 4.2.1: North American Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.2.2: North American Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others
• 4.3: European Radiotherapy Market
  • 4.3.1: European Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.3.2: European Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others
• 4.4: APAC Radiotherapy Market
  • 4.4.1: APAC Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.4.2: APAC Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others
• 4.5: ROW Radiotherapy Market
  • 4.5.1: ROW Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.5.2: ROW Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Radiotherapy Market by Type
  • 6.1.2: Growth Opportunities for the Global Radiotherapy Market by Application
  • 6.1.3: Growth Opportunities for the Global Radiotherapy Market by End Use
  • 6.1.4: Growth Opportunities for the Global Radiotherapy Market by Region
• 6.2: Emerging Trends in the Global Radiotherapy Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Radiotherapy Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Radiotherapy Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Ion Beam Applications
• 7.2: Elekta
• 7.3: Accuray Incorporated
• 7.4: Isoray
• 7.5: Becton
• 7.6: Dickinson and Company
• 7.7: Siemens Healthineers
• 7.8: ICAD
• 7.9: Nordion
• 7.10: MEVION MEDICAL SYSTEMS